B. Riley Wealth Advisors Inc. Decreases Holdings in Solventum Co. (NYSE:SOLV)

B. Riley Wealth Advisors Inc. reduced its position in Solventum Co. (NYSE:SOLV) by 17.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,697 shares of the company’s stock after selling 759 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Solventum were worth $257,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of SOLV. Assenagon Asset Management S.A. purchased a new position in Solventum in the second quarter worth about $347,000. Fifth Third Bancorp bought a new position in shares of Solventum in the 2nd quarter worth approximately $321,000. Louisiana State Employees Retirement System purchased a new position in shares of Solventum in the second quarter worth approximately $415,000. New York State Teachers Retirement System bought a new stake in Solventum during the second quarter valued at approximately $7,652,000. Finally, Retirement Systems of Alabama purchased a new stake in Solventum during the second quarter valued at approximately $1,612,000.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on SOLV shares. BTIG Research initiated coverage on shares of Solventum in a research report on Thursday, September 5th. They set a “neutral” rating for the company. Wolfe Research assumed coverage on Solventum in a report on Thursday, September 26th. They set a “peer perform” rating for the company. Piper Sandler raised their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley boosted their price objective on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Finally, Stifel Nicolaus initiated coverage on shares of Solventum in a report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $68.29.

Solventum Trading Up 0.0 %

SOLV stock opened at $66.83 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company’s fifty day moving average price is $70.90 and its 200-day moving average price is $63.55. Solventum Co. has a one year low of $47.16 and a one year high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.